Single-cell analysis of the progeria arterial wall reveals…
Detailed mapping of progeria's arterial damage reveals aging patterns that could help researchers understand how blood vessels age normally.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Targeting ACSF2 overcomes Ara-C resistance in acute myeloid leukemia…
Blocking a specific protein restores chemotherapy sensitivity in treatment-resistant leukemia, opening a potential path forward for patients who've exhausted standard options.
Promising but preliminaryLow-dose bevacizumab plus atezolizumab enhances transarterial…
Adding two targeted drugs to a liver cancer procedure reduces immune suppression and improves survival outcomes in early patient data.
Promising but preliminaryEnhanced acetate uptake and metabolism in endothelial cells promote…
Blocking a metabolic pathway in tumor blood vessels enhances immunotherapy effectiveness against liver cancer in laboratory models.
Promising but preliminaryd-serine as a metabolic immune checkpoint in the tumour microenvironment.
A naturally occurring molecule controls immune suppression in gut tumors, offering a fresh therapeutic target grounded in the microenvironment.